Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

ASPP2 Attenuation Is an Early Step in Leukemogenesis Facilitating Acquisition of Mutations

Kerstin M Kampa-Schittenhelm, Dr., MD, Figen Akmut, Barbara Illing, Charles Lopez, Marcus M Schittenhelm, Dr., MD

Blood (2014) 124 (21): 2221.

https://doi.org/10.1182/blood.V124.21.2221.2221

Published: 2014

Journal Articles

Gain-of-Function KIT Mutations Sensitize the Mutant Isoform to the Type I Tyrosine Kinase Inhibitor Crenolanib: A Rationale for the Therapeutic Use in Systemic Mastocytosis (SM) and Core Binding Factor Leukemias (CBFL)

Marcus M Schittenhelm, Dr., MD, Figen Akmut, Barbara Illing, Julia Frey, Katja Schuster, PhD, Abhijit Ramachandran, Lothar Kanz, MD, Kerstin M Kampa-Schittenhelm, Dr., MD

Blood (2014) 124 (21): 2230.

https://doi.org/10.1182/blood.V124.21.2230.2230

Published: 2014

Journal Articles

Methylation Of The 5’UTR Of Apoptosis Stimulating Protein Of p53-2 (ASPP2) Impairs Gene Expression and Associates With Aggressive Disease and Therapy Failure In Acute Leukemia

Marcus M Schittenhelm, Dr., MD, Barbara Illing, Figen Akmut, Gunnar Blumenstock, Konstanze Döhner, MD, Charles D Lopez, MD, PhD, Kerstin M Kampa-Schittenhelm, Dr., MD

Blood (2013) 122 (21): 3770.

https://doi.org/10.1182/blood.V122.21.3770.3770

Published: 2013

Journal Articles

Identification Of C-Terminal Truncated Splice Variants Of The Apoptosis-Stimulating Protein Of p53-2 (ASPP2) In Acute Leukemia Lacking The p53-Binding Site

Kerstin M Kampa-Schittenhelm, Dr.,, Barbara Illing, Figen Akmut, Michael Walter, PhD, Charles D Lopez, MD, PhD, Marcus M Schittenhelm, Dr.,

Blood (2013) 122 (21): 1270.

https://doi.org/10.1182/blood.V122.21.1270.1270

Published: 2013

Journal Articles

Heatshockproteins-60 and 90 Are Overexpressed In Leukemia Stem Cells and Stabilize Oncogene Signaling

Kerstin M Kampa-Schittenhelm, Dr., MD, Tanja Grandl, Figen Akmut, Barbara Illing, Marcus M Schittenhelm, Dr., MD

Blood (2013) 122 (21): 3952.

https://doi.org/10.1182/blood.V122.21.3952.3952

Published: 2013

Journal Articles

Induction Of Apoptosis By The Dual PI3K/Mtor Inhibitor NVP-BEZ235 Is Impaired By a Profound G1/G0 Arrest In Acute Leukemia Which Can Be Overcome By Combination Approaches

Kerstin M Kampa-Schittenhelm, Dr., MD, Figen Akmut, Barbara Illing, Marcus M Schittenhelm, Dr., MD

Blood (2013) 122 (21): 3856.

https://doi.org/10.1182/blood.V122.21.3856.3856

Published: 2013

NARROW

ASPP2 Attenuation Is an Early Step in Leukemogenesis Facilitating Acquisition of Mutations

Gain-of-Function KIT Mutations Sensitize the Mutant Isoform to the Type I Tyrosine Kinase Inhibitor Crenolanib: A Rationale for the Therapeutic Use in Systemic Mastocytosis (SM) and Core Binding Factor Leukemias (CBFL)

Methylation Of The 5’UTR Of Apoptosis Stimulating Protein Of p53-2 (ASPP2) Impairs Gene Expression and Associates With Aggressive Disease and Therapy Failure In Acute Leukemia

Identification Of C-Terminal Truncated Splice Variants Of The Apoptosis-Stimulating Protein Of p53-2 (ASPP2) In Acute Leukemia Lacking The p53-Binding Site

Heatshockproteins-60 and 90 Are Overexpressed In Leukemia Stem Cells and Stabilize Oncogene Signaling

Induction Of Apoptosis By The Dual PI3K/Mtor Inhibitor NVP-BEZ235 Is Impaired By a Profound G1/G0 Arrest In Acute Leukemia Which Can Be Overcome By Combination Approaches

Email alerts

ASH Publications

American Society of Hematology

ASPP2 Attenuation Is an Early Step in Leukemogenesis Facilitating Acquisition of Mutations

Gain-of-Function KIT Mutations Sensitize the Mutant Isoform to the Type I Tyrosine Kinase Inhibitor Crenolanib: A Rationale for the Therapeutic Use in Systemic Mastocytosis (SM) and Core Binding Factor Leukemias (CBFL)

Methylation Of The 5’UTR Of Apoptosis Stimulating Protein Of p53-2 (ASPP2) Impairs Gene Expression and Associates With Aggressive Disease and Therapy Failure In Acute Leukemia

Identification Of C-Terminal Truncated Splice Variants Of The Apoptosis-Stimulating Protein Of p53-2 (ASPP2) In Acute Leukemia Lacking The p53-Binding Site

Heatshockproteins-60 and 90 Are Overexpressed In Leukemia Stem Cells and Stabilize Oncogene Signaling

Induction Of Apoptosis By The Dual PI3K/Mtor Inhibitor NVP-BEZ235 Is Impaired By a Profound G1/G0 Arrest In Acute Leukemia Which Can Be Overcome By Combination Approaches

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only